Why the study?
Does intravenous nesiritide improve hemodynamic function and clinical status in patients hospitalized with decompensated congestive heart failure?
Does intravenous nesiritide improve hemodynamic function and clinical status in patients hospitalized with decompensated congestive heart failure?
Intravenous nesiritide is useful for improving hemodynamic function and clinical status in patients with decompensated heart failure.
Supports nesiritide for acute decompensated HF; confirms hemodynamic and clinical benefits in this RCT.
In patients hospitalized with decompensated congestive heart failure, nesiritide improves hemodynamic function and clinical status. Nesiritide is useful for the treatment of decompensated congestive heart failure.
No takes yet. Share an insight, caveat, or question.
Colucci et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: